• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24657
Date of Event 09/10/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Device is combination product.
 
Event or Problem Description
It was reported that guidewire and catheter entrapment occurred.The target lesion was located in the superficial femoral artery.A.035 magic torque guidewire was used with a 7x100, 130cm eluvia self-expanding stent.During the procedure the guidewire became stuck within the stent delivery system and could not be removed.The magic torque guidewire and the eluvia stent delivery system were removed together as one unit.The procedure was then completed using a new guidewire and a 7x40mm eluvia stent.No patient complications were reported.
 
Event or Problem Description
It was reported that guidewire and catheter entrapment occurred.The target lesion was located in the superficial femoral artery.A.035 magic torque guidewire was used with a 7x100, 130cm eluvia self-expanding stent.During the procedure the guidewire became stuck within the stent delivery system and could not be removed.The magic torque guidewire and the eluvia stent delivery system were removed together as one unit.The procedure was then completed using a new guidewire and a 7x40mm eluvia stent.No patient complications were reported.
 
Additional Manufacturer Narrative
Device is combination product.Device evaluated by manufacturer: the device was returned for analysis consisted of an eluvia self-expanding stent system with a 0.035 guidewire stuck inside the device.Visual examination revealed that the outer sheath is separated at the nosecone and the middle sheath can be seen.There is a kink to the middle sheath at the nosecone.The pull rack is separated, and the proximal section is missing.There is a bend in the outer sheath at 79.5cm from the nosecone.Microscopic examination revealed no additional damages.The devices were placed in a water bath for several days and the guidewire was able to be removed.It was noticed that there are kinks to the guidewire so functional testing was perform with a test guidewire, which revealed the wire advanced through the inner liner and was able to pass through the device.Inspection of the remainder of the device, revealed no other damage or irregularities.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Common Device Name
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key9131412
Report Number2134265-2019-11744
Device Sequence Number2262519
Product Code NIU
UDI-Device Identifier08714729876724
UDI-Public08714729876724
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P180011
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/11/2019
1 Device was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/12/2020
Device Model Number24657
Device Catalogue Number24657
Device Lot Number0023046808
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/27/2019
Initial Date Received by Manufacturer 09/10/2019
Supplement Date Received by Manufacturer10/23/2019
Initial Report FDA Received Date09/27/2019
Supplement Report FDA Received Date11/11/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
-
-